Listening Benefits From a Hearing-aid App, a Personal Sound Amplification Product, and a Hearing Aid in Hearing-impaired Listeners

Seoul National University Hospital1 site in 1 country30 target enrollmentAugust 10, 2021

ConditionsHearing Disorders

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hearing Disorders
Sponsor: Seoul National University Hospital
Enrollment: 30
Locations: 1
Primary Endpoint: The hearing level threshold (decibel) after each treatment
Status: Recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Interest and demand for sound amplifiers are increasing due to the burden of purchasing hearing aids and technological advances in healthcare products, and the demand is expected to increase rapidly. For sensorineural hearing loss patients, who are subject to wearing hearing aids, it aims to compare the effect of hearing aid application and personal sound amplification product (PSAPs) compared to the hearing aids

Registry

clinicaltrials.gov

Start Date

August 10, 2021

End Date

August 9, 2023

Last Updated

3 years ago

Study Type

Interventional

Study Design

Crossover

Sex

All

Investigators

Sponsor

Seoul National University Hospital

Responsible Party

Principal Investigator

Moo Kyun, Park

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

•Adults over the age of 20 who speak Korean as their mother tongue and have no mental or physical limitations in conducting test.
•Hearing loss patients with a hearing threshold of 26 dB or higher in the four frequency (0.5, 1, 2, 4 kHz)
•Those who do not have a history of neurological disease, cognitive disorder, learning disorder, or language disorder at the time of recruitment

Exclusion Criteria

•In case that communication is difficult, equipment cannot be handled, or it is difficult to cooperate with the inspection
•Acoustic nerve lesions or central nervous system disease
•Those suspected of having false hearing loss
•Those who have secondary benefits related to clinical trials